{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:53:45Z","timestamp":1780044825225,"version":"3.53.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institutes of Neurologic Diseases and Stroke"},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["R01NS086312"],"award-info":[{"award-number":["R01NS086312"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["K01TW010268"],"award-info":[{"award-number":["K01TW010268"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["R25TW009345"],"award-info":[{"award-number":["R25TW009345"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.mmcr.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T18:18:23Z","timestamp":1511720303000},"page":"30-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis"],"prefix":"10.1016","volume":"19","author":[{"given":"Edward","family":"Mpoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Abassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mmcr.2017.11.004_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mmcr.2017.11.004_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.mmcr.2017.11.004_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"11","key":"10.1016\/j.mmcr.2017.11.004_bib4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.mmcr.2017.11.004_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/13693786.2012.715763","article-title":"Fluconazole resistance in cryptococcal disease: emerging or intrinsic?","volume":"51","author":"Cheong","year":"2013","journal-title":"Med. Mycol."},{"issue":"1","key":"10.1016\/j.mmcr.2017.11.004_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"47","author":"Pfaller","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mmcr.2017.11.004_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-015-1023-8","article-title":"Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.mmcr.2017.11.004_bib8","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of cryptococcus neoformans in Uganda","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.mmcr.2017.11.004_bib9","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"Sionov","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.mmcr.2017.11.004_bib10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1534\/g3.116.037499","article-title":"A population genomics approach to assessing the genetic basis of within-host microevolution underlying recurrent cryptococcal meningitis infection","volume":"7","author":"Rhodes","year":"2017","journal-title":"G3"},{"issue":"2","key":"10.1016\/j.mmcr.2017.11.004_bib11","doi-asserted-by":"crossref","first-page":"ofw076","DOI":"10.1093\/ofid\/ofw076","article-title":"Retrospective study of cryptococcal meningitis with elevated minimum inhibitory concentration to fluconazole in immunocompromised patients","volume":"3","author":"Nasri","year":"2016","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.mmcr.2017.11.004_bib12","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","article-title":"Correlation of fluconazole MICs with clinical outcome in cryptococcal infection","volume":"44","author":"Aller","year":"2000","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753917300623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753917300623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:08:25Z","timestamp":1570381705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753917300623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":12,"alternative-id":["S2211753917300623"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2017.11.004","relation":{},"ISSN":["2211-7539"],"issn-type":[{"value":"2211-7539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.","name":"copyright","label":"Copyright"}]}}